$6.91
0.152.22%
At Close: -
$6.90
-0.0100-0.14%
After Hours: 7:46 PM EDT
15 minutes delayed
Recursion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.40 | $-0.40 | 0.00 % |
Mar 2024 | 2024-05-09 | $-0.39 | $-0.42 | 7.14 % |
Dec 2023 | 2024-02-27 | $-0.42 | $-0.45 | 6.67 % |
Sep 2023 | 2023-11-09 | $-0.43 | $-0.38 | -13.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $14.42M | $13.75M | 4.85 % |
Mar 2024 | 2024-05-09 | $13.49M | $12.65M | 6.65 % |
Dec 2023 | 2024-02-27 | $10.89M | $20.53M | -46.9 % |
Sep 2023 | 2023-11-09 | $10.53M | $12.87M | -18.2 % |
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.40, which hit the estimate of $-0.40.
The Actual Revenue was $14.4M, which beat the estimate of $13.8M.
Browse earnings estimates, EPS, and revenue on all stocks.